Total Payments
$15,177
2024 Payments
$1,144
Companies
41
Transactions
444
Medicare Patients
11,118
Medicare Billing
$776,529
Payment Breakdown by Category
Food & Beverage$8,554 (56.4%)
Research$5,000 (32.9%)
Consulting$1,500 (9.9%)
Education$122.99 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,554 | 440 | 56.4% |
| Unspecified | $5,000 | 1 | 32.9% |
| Consulting Fee | $1,500 | 1 | 9.9% |
| Education | $122.99 | 2 | 0.8% |
Payments by Type
General
$10,177
443 transactions
Research
$5,000
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $5,000 | 1 | $0 (2023) |
| ABBVIE INC. | $2,930 | 124 | $0 (2024) |
| Allergan, Inc. | $2,022 | 20 | $0 (2022) |
| GENZYME CORPORATION | $617.71 | 38 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $585.27 | 28 | $0 (2024) |
| MAYNE PHARMA INC. | $380.97 | 43 | $0 (2020) |
| LEO Pharma Inc. | $368.16 | 23 | $0 (2023) |
| Amgen Inc. | $342.88 | 15 | $0 (2021) |
| Janssen Biotech, Inc. | $292.25 | 12 | $0 (2024) |
| Lilly USA, LLC | $237.16 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,144 | 35 | ABBVIE INC. ($579.21) |
| 2023 | $5,917 | 40 | Eli Lilly and Company ($5,000) |
| 2022 | $998.08 | 61 | ABBVIE INC. ($282.78) |
| 2021 | $853.52 | 59 | AbbVie Inc. ($307.59) |
| 2020 | $477.20 | 24 | AbbVie Inc. ($73.60) |
| 2019 | $1,501 | 68 | AbbVie, Inc. ($566.90) |
| 2018 | $1,402 | 76 | AbbVie, Inc. ($361.70) |
| 2017 | $2,884 | 81 | Allergan Inc. ($1,752) |
All Payment Transactions
444 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological), KYBELLA | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Immunology | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $42.35 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Immunology | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.48 | General |
| Category: Immunology | ||||||
| 09/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Immunology | ||||||
| 09/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: FACIAL AESTHETICS | ||||||
| 09/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $7.26 | General |
| 08/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $32.59 | General |
| 08/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $129.77 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.02 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: IMMUNOLOGY | ||||||
| 07/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Immunology | ||||||
| 07/17/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $18.97 | General |
| 06/28/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $19.32 | General |
| 05/13/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Immunology | ||||||
| 05/09/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $19.04 | General |
| 05/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.41 | General |
| Category: Immunology | ||||||
| 04/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $37.58 | General |
| Category: Immunology | ||||||
| 04/18/2024 | Medimetriks Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $27.79 | General |
| 03/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: IMMUNOLOGY | ||||||
| 03/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PSOSA (PSORIASIS SPECIAL AREAS) - A US-BASED SINGLE-ARM PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY OF NAIL AND SCALP PSORIASIS IMPROVEMENT IN PATIENTS TREATED WITH IXEKIZUMAB | Eli Lilly and Company | $5,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 2,630 | 3,702 | $485,108 | $189,941 |
| 2022 | 15 | 2,954 | 4,180 | $541,166 | $208,471 |
| 2021 | 15 | 2,885 | 4,100 | $514,931 | $204,100 |
| 2020 | 14 | 2,649 | 3,821 | $492,505 | $174,017 |
Total Patients
11,118
Total Services
15,803
Medicare Billing
$776,529
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 753 | 1,044 | $130,500 | $59,738 | 45.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 504 | 643 | $93,489 | $42,585 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 230 | $39,100 | $18,217 | 46.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 353 | 481 | $75,998 | $16,955 | 22.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 149 | 168 | $31,920 | $12,970 | 40.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 197 | 321 | $23,152 | $12,206 | 52.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 183 | 217 | $19,530 | $8,705 | 44.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 50 | 64 | $21,632 | $6,345 | 29.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $10,395 | $4,424 | 42.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 23 | 28 | $12,012 | $3,367 | 28.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 156 | 406 | $20,300 | $1,848 | 9.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 15 | 16 | $2,880 | $1,403 | 48.7% |
| 69100 | Biopsy of ear | Office | 2023 | 19 | 21 | $4,200 | $1,177 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 878 | 1,223 | $152,875 | $69,461 | 45.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 535 | 698 | $104,002 | $44,938 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 251 | $42,670 | $20,674 | 48.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 395 | 539 | $85,162 | $19,736 | 23.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 183 | 311 | $23,145 | $11,680 | 50.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 225 | 265 | $23,850 | $10,134 | 42.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 121 | 125 | $23,750 | $9,897 | 41.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 47 | 56 | $18,928 | $5,702 | 30.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 89 | 89 | $14,685 | $5,355 | 36.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 26 | 26 | $11,154 | $3,370 | 30.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 34 | 34 | $6,295 | $2,668 | 42.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 170 | 495 | $24,750 | $2,374 | 9.6% |
About Dr. Catherine Pointon, MD
Dr. Catherine Pointon, MD is a Specialist healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386608115.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Catherine Pointon, MD has received a total of $15,177 in payments from pharmaceutical and medical device companies, with $1,144 received in 2024. These payments were reported across 444 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($8,554).
As a Medicare-enrolled provider, Pointon has provided services to 11,118 Medicare beneficiaries, totaling 15,803 services with total Medicare billing of $776,529. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Dermatology
- Location Charlotte, NC
- Active Since 04/17/2006
- Last Updated 04/16/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386608115
Products in Payments
- TALTZ (Drug) $5,216
- RHOFADE (Drug) $1,778
- Humira (Biological) $1,001
- SKYRIZI (Biological) $871.10
- BOTOX (Biological) $461.48
- COSENTYX (Biological) $440.43
- DUPIXENT (Biological) $423.83
- DORYX (Drug) $380.97
- Enbrel (Biological) $316.12
- EUCRISA (Drug) $231.73
- DUPIXENT (Drug) $193.88
- ENSTILAR (Drug) $186.01
- Seysara (Drug) $183.53
- ADBRY (Biological) $182.15
- Sotyktu (Drug) $179.20
- RINVOQ (Biological) $175.01
- TREMFYA (Drug) $166.85
- Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug) $121.60
- Skyrizi (Biological) $111.82
- REMICADE (Biological) $105.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Charlotte
Stephan Finical, Md, MD
Specialist — Payments: $301,306
Specialist $301,306
Kevin Smith, Md, MD
Specialist — Payments: $134,294
Specialist $134,294
Gary Slaughter, Md, MD
Specialist — Payments: $114,708
Specialist $114,708
Gerald Aronoff, Md, MD
Specialist — Payments: $82,668
Specialist $82,668
Dr. David Lane, M.d, M.D
Specialist — Payments: $48,057
Specialist $48,057
Dr. Jay Levy, M.d, M.D
Specialist — Payments: $22,093
Specialist $22,093